TNXP - Tonix Pharmaceuticals Holding Corp.
13.45
-0.270 -2.007%
Share volume: 279,479
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$13.72
-0.27
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-16-2024 | 11-12-2024 | 03-18-2025 | 05-12-2025 | 08-11-2025 | 11-10-2025 | |
| Assets | ||||||||
| Total Assets | 135.343 M | 70.307 M | 94.989 M | 162.890 M | 192.870 M | 187.359 M | 252.440 M | |
| Current Assets | 30.098 M | 25.287 M | 50.543 M | 119.002 M | 149.573 M | 143.535 M | 208.071 M | |
| Inventories | 12.351 M | 9.457 M | 7.931 M | 8.408 M | 8.136 M | 5.986 M | 5.729 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 7.049 M | 4.156 M | 28.233 M | 98.776 M | 131.716 M | 125.331 M | 190.055 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 93.058 M | 43.247 M | 42.747 M | 42.252 M | 41.766 M | 42.335 M | 42.574 M | |
| Other Assets | 12.187 M | 1.773 M | 1.699 M | 1.636 M | 1.531 M | 1.489 M | 1.795 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 135.343 M | 70.307 M | 94.989 M | 162.890 M | 192.870 M | 187.359 M | 252.440 M | |
| Total liabilities | 27.200 M | 28.204 M | 20.778 M | 23.332 M | 12.474 M | 19.358 M | 21.297 M | |
| Total current liabilities | 20.479 M | 22.043 M | 15.181 M | 18.307 M | 12.146 M | 19.061 M | 21.031 M | |
| Accounts Payable | 17.382 M | 18.946 M | 12.086 M | 15.213 M | 11.911 M | 18.866 M | 20.872 M | |
| Other liabilities | 0.000 | 493.000 K | 425.000 K | 358.000 K | 328.000 K | 297.000 K | 266.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 6.158 M | 5.668 M | 5.172 M | 4.667 M | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 493.000 K | 425.000 K | 358.000 K | 328.000 K | 297.000 K | 266.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 108.143 M | 42.103 M | 74.211 M | 139.558 M | 180.396 M | 168.001 M | 231.143 M | |
| Common stock | 723.980 M | 736.719 M | 783.047 M | 870.507 M | 928.185 M | 944.066 M | 1.039 B | |
| Retained earnings | -615.597 M | -694.373 M | -708.586 M | -730.694 M | -747.523 M | -775.795 M | -807.805 M |